icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
Washington on 04-08
November 2022
Back grey_arrow_rt.gif
 
 
 
The impact of direct-acting antiviral treatment for HCV on
hepatocellular carcinoma risk in a large population-based cohort study

 
 
  AASLD 2022 Nov 4-8
 
Janjua NZ1,2, Wong S, 1 Jeong D1,2, Makuza JD 1,2, Garcia HV1, Binka M1, Adu P1, Yu A1, Yoshida EM,4 Ramji A,4 Bartlett S1,3, Darvishian M1, 5, Alvarez M1, Krajden M1,3, The BC-HTC Team* 1 BC Centre for Disease Control, Vancouver, BC; 2 School of Population and Public Health; 3 Dept. of Pathology and Laboratory Medicine, 4 Division of Gastroenterology University of British Columbia, 5 BC Cancer, Vancouver, BC, Canada

1117221

1117222

1117223

1117224

1117225

1117226

http://bchtc.med.ubc.ca/